FTC argues against proposed antitrust exemption for independent community pharmacies in Congressional testimony
The Federal Trade Commission testified on a proposed antitrust exemption for independent pharmacies before the U.S. House Judiciary Committee’s Subcommittee on Intellectual Property, Competition, and the Internet. H.R. 1946, “Preserving Our Hometown Independent Pharmacies Act of 2011,” would allow community pharmacies to engage in collective bargaining for higher fees and better contract terms from health plans.
The FTC argued that the exemption would lead to diminished competition and innovation. The decreased competition would then lead to price increases in health care–health plans would have to pay higher drug dispensing fees to pharmacists that would then be passed on to consumers.
Full content: FTC Press Release
Related content: Competition Come Full Circle? Pending Legislation to Repeal the U.S. Railroad Exemptions (Chris Sagers, Cleveland-Marshall School of Law)
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI